Buy Slimming Pills
As a regulated clinic we are able to prescribe slimming pills to help you lose weight. We offer a free, no obligation online consultation to check your suitability. Next day delivery in the UK.
Our Diet and Slimming Pill Policy
We believe that the best way to lose weight is by following a healthy eating plan and taking a moderate amount of exercise every day, as laid out on the obesity advice page on our website. Where an effort in this direction has failed to produce significant results or you just need that extra push, we will be happy to help you achieve your goals with slimming pills so long as we agree that it is an appropriate course of action based on your personal circumstances. However, as a regulated clinic, we will only ever advise you on prescription medications which have been through exhaustive clinical trials to demonstrate their safety and efficacy. We never recommend herbal diet or slimming pills or anything that you can buy over the counter because they tend to be ineffective or non-proven because of the lack of clinical data.
Prescription Slimming Pills
There is only one prescription slimming pill currently licensed in the UK for medium to long term use with a demonstrated safety and efficacy level. There are a number of new slimming pills currently under consideration by the regulatory authorities in the EU and the US and we can notify you when (and if) they become available to prescribe if you take a few moments to register with us.
Xenical, also known as Orlistat, is a slimming medication which works in a localised way to prevent the digestion and absorption of a degree of dietary fat. As the medication works locally in the digestive tract, there tend to be fewer potential side effects associated with this medication than with its centrally acting competitors. All medications have potential side effects but for most patients, most side effects which are experienced on Xenical will normally disappear with an adjustment to diet.
Because of the way that Xenical works, it is essential that you make sure that you have a mildly low fat diet before you begin taking the medication. Many people mistakenly think that Xenical is only suitable for people with a high fat diet – nothing could be further from the truth! If you have a high fat diet and you take Xenical, you are most likely to experience undesirable gastrointestinal side effects such as very loose bowel movements and an urgency to have them. So long as you follow the dietary advice, you should escape these side effects.
Xenical may not be suitable for everyone and it is only available on prescription. Some pharmacies have a special dispensation to provide Xenical under Patient Group Direction so it is available in certain places in the UK following an interview with a pharmacist. We provide the medication on prescription following an online consultation with a registered doctor.
Orlistat is available as Alli, an over the counter pharmacy slimming pill, which contains 60 mg of Orlistat rather than 120 mg when it is prescribed as Xenical. Given the dosage difference, Xenical is a more effective slimming tablet than Alli.
We have provided further information on Xenical which is based on the approved patient information leaflet which accompanies the medication. If we prescribe this medication for you, you will be entitled to register at http://www.xenicalmap.co.uk which is an online resource provided by Roche, the manufacturer of Xenical or Orlistat. This is only available to people who have actually been prescribed the medication and you will be issued with a code to allow you to register online.
The three medications that are currently under consideration at the FDA in the United States are:
This is a centrally acting drug that is a completely new compound. Weight loss was moderate in clinical trials but above the minimum level required of a weight loss medication before approval is given. The FDA has raised concerns about mammary tumours in rats during Phase I studies. These were thought to be caused by extended exposure to high levels of prolactin. The mechanism that causes these tumours may not be relevant to humans as there are a number of currently licensed drugs that had this effect on rodents but not on humans. Clearly this issue needs to be resolved before a license is granted. Click here for further information on Lorcaserin.
Qsiva is a new medication that combines a low dose of Phentermine with Topiramate. Qsiva acts as an appetite suppressant and had very high levels of sustained weight loss in clinical trials. The FDA is concerned about the possibility of birth defects so they have asked for further information. Concern was also raised earlier about cardiovascular risk but there were no particular issues identified during the two year phase III clinical trial. An application was made in December 2010 to the European Medicines Agency for a license and we should know the response later this year. Please follow this link to get further information on Qsiva.
Mysimba contains a formulation of bupropion and naltrexone, which are both currently licensed separately for anti-addiction indications. The combination of these two drugs has produced a reasonably effective appetite suppressant but the FDA is very concerned about the effect on the heart muscle so has insisted on a further clinical study. The company behind Mysimba has requested that this study takes place after the medication has been licensed but given the large number of people who may take the medication, such permission is unlikely to be forthcoming, even although this was the recommendation of an influential FDA committee. No application has currently been made in the EU. Please navigate to the Mysimba page for further information.
If you would like a consultation to help you lose weight then please click on the Free Consultation button below. If you ask to be put on our mailing list during the registration process then we can let you know when (and if) the above new medications become available to prescribe.
Slimming Pills News
A couple of months ago we reported that Orexigen would be submitting an application for a marketing authorisation to the European Medicines Agency for Contrave, its obesity medication. That submission has now happened and the EMA will be accepting interim results from the company's cardiovascular…Read full article >
We wrote on this blog a few months ago about the risks associated with Dinitrophenol and warned the public of the dangers of products contain this chemical. Finally, the UK Government is on the case and doctors have been officially alerted to the dangers of Dinitrophenol (DNP), which is an…Read full article >